Neuren Pharmaceuticals | NEU - Capital Social Ordinario

Precio De Mercado
12.49
Cambio Diario
0.13 1.05%
Mensual
7.95%
Anual
22.81%
Q2 Expectativa
12.27




Capital Social Ordinario Cambio Fecha
Akebia Therapeutics USD 265.42M 199K 2025-12
Alaunos Therapeutics USD 2.21M 131K 2025-09
Clinuvel Pharmaceuticals AUD 50.2M 77.11K 2025-12
Dianthus Therapeutics USD 43.22M 368.53K 2025-12
Genetic Signatures AUD 227.14M 0 2025-12
Ionis Pharmaceuticals USD 161.97M 836K 2025-12
Medical Developments International AUD 112.66M 2.35M 2025-12
Neuren Pharmaceuticals AUD 126.64M 38.63M 2025-12
Organon & Co USD 259.98M 18K 2025-09
Paradigm Biopharmaceuticals AUD 428.52M 39.09M 2025-12
PYC Therapeutics AUD 597.24M 366.66M 2025-12
Starpharma Holdings AUD 419.92M 179.17M 2025-12
Tectonic Therapeutic USD 18.74M 25.03K 2025-12
Telix Pharmaceuticals AUD 338.78M 379K 2025-12
Viatris USD 1.16B 6.55M 2025-09
Xeris Pharmaceuticals USD 166.22M 687.16K 2025-12